Scheduled Maintenance. MDBriefCase will be down on Sunday, November 27, 2022.
We are busy updating our website and learning platform to enhance your learning experience. We’ll be back up and running again before long, so please try again soon.

The content on this page is designed for Middle East. Check webinars designed for Canada (EN)

Economic Considerations in Managing Obesity: The Forgotten Pandemic

Saturday, October 21st, 2023 | 10:00 AM - 4:00 PM KSA (Riyadh) | Crowne Plaza RDC | Riyadh

Google Maps Location LinkCrowne Plaza RDC

Duration – 6 hours

Novo Nordisk and MDBriefCase are pleased to invite you to the upcoming event.

The rate of obesity and overweight in Saudi Arabia has nearly doubled over the past 50 years, making obesity management an essential topic for healthcare professionals. Join us in-person on Saturday, October 21st to learn more about obesity management in Saudi Arabia from international and local experts.

In this in-person event, you will learn to:

  1. Describe the clinical and economic burden of obesity on the Saudi healthcare
    system.
  2. Explain the long-term impact of obesity on the affected individual and society
    in general.
  3. Discuss the important role of obesity management on reaching targets within
    the Saudi Healthcare Transformation Program.
  4. Assess the value of obesity pharmacotherapy in reducing the costs of the
    comorbid conditions associated with obesity and improvement in patient
    quality of life.


This event will feature:

Arya

Dr. Arya Sharma

MD, DSc (hon), FRCPC

Hana

Dr. Hana Abdulkareem

BSc Pharm, MSc

M-Alshennawi

Dr. Mohamed Alshenawi

BSc Pharm, MBA

Hajer

Dr. Hajer Yousef Almudaiheem

PharmD, MSc

Ali Alrumaih

Dr. Ali Alromeih

BSc Pharm, PhD

This program is supported by Novo Nordisk.

Disclaimer: By submitting your information through this portal, you are consenting & approving that your information will be shared with the meeting organiser (Novo Nordisk), who will use it to communicate with you regarding this event logistics and share it with the relevant government authorities who require documentation for the services provided.

Novo Nordisk in accordance with International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) does not extend invitations to spouses, partners or any accompanying person; This includes travel arrangements, accommodation & meals.

In alignment with Novo Nordisk Business Ethics rules, travel arranged for delegates should be booked as close to the event as possible – within 24 hours of the beginning or end of the meeting – Neither Novo Nordisk nor its third party travel agents may facilitate a request to extend the arrival or delay the departure beyond 24 hours of the start/close of event, and/or change the return ticket’s destination to be from another city.

Photos, videos and meeting recording may be used on social media and Novo Nordisk HCP portal.

Registration Form

Select Which Webinars You’d Like to Attend